The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

24 articles for G Schneider


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
De Novo Design at the Edge of Chaos.EBI
Swiss Federal Institute of Technology (Eth)
Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like properties.EBI
Goethe-University Frankfurt
Identification of pirinixic acid derivatives bearing a 2-aminothiazole moiety combines dual PPARa/¿ activation and dual 5-LO/mPGES-1 inhibition.EBI
Goethe-University Frankfurt
Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist.EBI
Goethe-University Frankfurt
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR).EBI
Goethe-University Frankfurt
Synthesis and pharmacological characterization of benzenesulfonamides as dual species inhibitors of human and murine mPGES-1.EBI
Goethe-University Frankfurt
Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.EBI
Goethe-University Frankfurt
Structure-guided design of novel thiazolidine inhibitors of O-acetyl serine sulfhydrylase from Mycobacterium tuberculosis.EBI
Karolinska Institutet
Discovery of novel inhibitors targeting the Mycobacterium tuberculosis O-acetylserine sulfhydrylase (CysK1) using virtual high-throughput screening.EBI
Birla Institute of Technology
Discovery and biological evaluation of a novel class of dual microsomal prostaglandin E2 synthase-1/5-lipoxygenase inhibitors based on 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid.EBI
Zafes/Liff/Goethe University Frankfurt
Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1).EBI
Johann Wolfgang Goethe University
A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.EBI
Goethe-University Frankfurt
SAR of novel biarylmethylamine dopamine D4 receptor ligands.EBI
Darmstadt
Truxillic acid derivatives act as peroxisome proliferator-activated receptor gamma activators.EBI
Goethe-University Frankfurt
Rational design of a pirinixic acid derivative that acts as subtype-selective PPARgamma modulator.EBI
Goethe-University Frankfurt
2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.EBI
Johann Wolfgang Goethe University
Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1.EBI
Merz Pharmaceuticals
Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.EBI
Johann Wolfgang Goethe-UniversitäT
Profiling of in vitro activities of urea-based inhibitors against cysteine synthases from Mycobacterium tuberculosis.EBI
Karolinska Institutet
Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors.EBI
Johann Wolfgang Goethe-UniversitäT
Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis.EBI
Institutet
Vanillin-derived antiproliferative compounds influence Plk1 activity.EBI
Johann-Wolfgang-Goethe University of Frankfurt
Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics.EBI
Swiss Federal Institute of Technology (Eth)